MK-6194 (PT101)

PT101 · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-6194 (PT101), covering 2025-03-24 to 2025-03-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MK-6194 (PT101) in Participants With Active Ulcerative Colitis (UC) (MK-6194-002) [Phase 1]